Changhong Tan1, Xi Liu1, Lijuan Mo1, Xin Wei1, Wuxue Peng1, Hui Wang1, Wen Zhou1, Jin Jiang1, Yangmei Chen1, Lifen Chen2. 1. Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, 400010, China. 2. Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, 400010, China. lifen_chen@cqmu.edu.cn.
Abstract
BACKGROUND AND PURPOSE: Conflicts exist regarding relationship between prior/new statin use, cholesterol, and early poststroke intracranial hemorrhage (ICH) in acute ischemic stroke (AIS) patients. This meta-analysis is aimed at evaluating the safety of prior/new statin use, cholesterol level and risk of ICH in AIS patients. METHODS: We searched PubMed and Embase for studies examining relation between statin use, cholesterol level, and early poststroke ICH in AIS. Included studies should report risk of early poststroke symptomatic ICH (sICH) or overall ICH. A random-effects model was used to pool the data. RESULTS: Twenty-five articles involving 26,327 participants were included, among whom 925 had sICH. Prior statin use was not associated with overall ICH (adjusted odds ratio (OR), 1.478; 95% confidence interval (CI), 0.924-2.362; p = 0.103) and sICH in patients who received thrombolysis (adjusted OR, 1.567; 95% CI, 0.994-2.471; p = 0.053) or overall ICH in patients, most of whom had not received recanalization therapy (crude OR, 1.342; 95% CI, 0.872-2.065; p = 0.181). New statin use was associated with decreased sICH after recanalization therapy (crude OR, 0.292; 95% CI, 0.168-0.507; p < 0.001).Cholesterol level was not associated with overall ICH. CONCLUSION: Prior/new statin use and lower cholesterol level are not risk factors for sICH and overall ICH in AIS patients, whether or not the patient has received recanalization therapy. New statin use is likely associated with decreased sICH.
BACKGROUND AND PURPOSE: Conflicts exist regarding relationship between prior/new statin use, cholesterol, and early poststroke intracranial hemorrhage (ICH) in acute ischemic stroke (AIS) patients. This meta-analysis is aimed at evaluating the safety of prior/new statin use, cholesterol level and risk of ICH in AISpatients. METHODS: We searched PubMed and Embase for studies examining relation between statin use, cholesterol level, and early poststroke ICH in AIS. Included studies should report risk of early poststroke symptomatic ICH (sICH) or overall ICH. A random-effects model was used to pool the data. RESULTS: Twenty-five articles involving 26,327 participants were included, among whom 925 had sICH. Prior statin use was not associated with overall ICH (adjusted odds ratio (OR), 1.478; 95% confidence interval (CI), 0.924-2.362; p = 0.103) and sICH in patients who received thrombolysis (adjusted OR, 1.567; 95% CI, 0.994-2.471; p = 0.053) or overall ICH in patients, most of whom had not received recanalization therapy (crude OR, 1.342; 95% CI, 0.872-2.065; p = 0.181). New statin use was associated with decreased sICH after recanalization therapy (crude OR, 0.292; 95% CI, 0.168-0.507; p < 0.001).Cholesterol level was not associated with overall ICH. CONCLUSION: Prior/new statin use and lower cholesterol level are not risk factors for sICH and overall ICH in AISpatients, whether or not the patient has received recanalization therapy. New statin use is likely associated with decreased sICH.
Authors: Mauro Cimino; Paolo Gelosa; Anita Gianella; Elena Nobili; Elena Tremoli; Luigi Sironi Journal: Neuroscientist Date: 2007-06 Impact factor: 7.519
Authors: S T Engelter; L Soinne; P Ringleb; H Sarikaya; R Bordet; J Berrouschot; C Odier; M Arnold; G A Ford; A Pezzini; A Zini; K Rantanen; A Rocco; L H Bonati; L Kellert; D Strbian; A Stoll; N Meier; P Michel; R W Baumgartner; D Leys; T Tatlisumak; P A Lyrer Journal: Neurology Date: 2011-08-17 Impact factor: 9.910
Authors: Joan Montaner; Alejandro Bustamante; Silvia García-Matas; Maite Martínez-Zabaleta; Carmen Jiménez; Javier de la Torre; Francisco R Rubio; Tomás Segura; Jaime Masjuán; David Cánovas; Mar Freijo; Raquel Delgado-Mederos; Javier Tejada; Aida Lago; Yolanda Bravo; Natália Corbeto; Dolors Giralt; Bárbara Vives-Pastor; Anna de Arce; Francisco Moniche; Pilar Delgado; Marc Ribó Journal: Stroke Date: 2016-10-06 Impact factor: 7.914
Authors: Marc S Sabatine; Stephen D Wiviott; KyungAh Im; Sabina A Murphy; Robert P Giugliano Journal: JAMA Cardiol Date: 2018-09-01 Impact factor: 14.676
Authors: Jan F Scheitz; David J Seiffge; Serdar Tütüncü; Henrik Gensicke; Heinrich J Audebert; Leo H Bonati; Jochen B Fiebach; Christopher Tränka; Philippe A Lyrer; Matthias Endres; Stefan T Engelter; Christian H Nolte Journal: Stroke Date: 2013-12-24 Impact factor: 7.914
Authors: Joan Montaner; Carlos A Molina; Jasone Monasterio; Sonia Abilleira; Juan F Arenillas; Marc Ribó; Manolo Quintana; José Alvarez-Sabín Journal: Circulation Date: 2003-02-04 Impact factor: 29.690
Authors: Hebun Erdur; Alexandros Polymeris; Ulrike Grittner; Jan F Scheitz; Serdar Tütüncü; David J Seiffge; Heinrich J Audebert; Christian H Nolte; Stefan T Engelter; Andrea Rocco Journal: Front Neurol Date: 2018-02-16 Impact factor: 4.003